Purchase Order 36C26323P0039

Award Date 10/13/22
Potential Completion Date 5/1/23
Potential Value $104K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Omaha, NE 68105, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price purchase order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned for-profit company, to provide Optune Plus Transducers. The order has a potential value of $49,748.73 and a completion date of May 31, 2024. This order is part of a larger 5-year Federal Supply Schedule (FSS) contract with the VA VHA valued at up to $28.85 million, which allows the VA to efficiently procure Novocure's Optune tumor...
This is a firm fixed price purchase order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned for-profit company. The contract has a potential value of $99,173.46 and is to provide Novocure's Optune tumor treating fields (TTFields) therapy devices, transducers, rentals, and support services to VA medical centers and facilities nationwide. Novocure holds a 5-year Federal Supply Schedule (FSS) contract with the VA VHA, valued at...
This $99,497.46 firm fixed-price purchase order was awarded by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The contract is for the delivery of Novocure's Optune line of Tumor Treating Fields (TTFields) therapy devices, transducer arrays, rental equipment, and associated support services to VA medical centers. Novocure's proprietary Optune system delivers alternating electric...
This is a $49,748.73 firm fixed-price purchase order contract awarded by the Veterans Health Administration (VHA) of the U.S. Department of Veterans Affairs (VA) to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The contract is for the provision of Novocure's Optune line of tumor treating fields (TTFields) therapy devices, transducer arrays, rental equipment, and associated support services. The contract supports the VA's efforts to expand veteran access to...
This is a firm-fixed-price purchase order awarded to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices, by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The contract has a ceiling value of $16,582.91 and a performance period ending on October 9, 2024. The award is for Optune Plus Transducer, part of Novocure's proprietary Optune system that delivers Tumor Treating Fields (TTFields) therapy for the treatment of glioblastoma and other...
This is a firm fixed price purchase order from the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned for-profit company, to provide its Optune electrical field therapy transducers and related rental and support services. The contract, with a potential value of $105,000.00, has a completion date of September 30, 2020 and was awarded on May 1, 2020. The order is to deliver Novocure's Optune tumor treating fields (TTFields) therapy...
The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) awarded a firm fixed price purchase order to Novocure Inc., a foreign-owned for-profit organization, to provide its Optune tumor treating fields (TTFields) therapy devices, transducers, rentals, and support services. The $126,000.00 contract is for delivery of these medical technologies to VA facilities nationwide, including locations in Portsmouth, New Hampshire; San Antonio, Texas; Des Moines, Iowa; and others, to...
This is a firm fixed-price purchase order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The contract, valued at $21,000.00, is for the delivery of Novocure's Optune Plus Transducers, which are part of the company's Optune system for delivering Tumor Treating Fields (TTFields) therapy to treat solid tumor cancers, including glioblastoma and mesothelioma. This contract is not...
This is a firm fixed-price purchase order contract awarded by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The contract, valued at $49,748.73, is for the provision of Novocure's Optune line of Tumor Treating Fields (TTFields) therapy devices, transducer arrays, rental equipment, and associated support services. The contract does not utilize any set-aside designations. Novocure acts...
This is a firm fixed-price purchase order contract awarded by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The $33,165.82 contract is for the provision of Novocure's Optune line of Tumor Treating Fields (TTFields) therapy devices, transducer arrays, rental equipment, and associated support services. This order is issued under Novocure's existing 5-year, $28.85 million Federal...

This is a firm fixed price purchase order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned for-profit organization, to provide its Optune tumor treating fields (TTFields) therapy devices, transducer arrays, and related equipment rentals and support services for the treatment of solid tumor cancers, including glioblastoma, for veterans at VA medical centers and clinics. The contract has a potential value of $103,914.55 and a completion date of May 1, 2023. This order is part of a larger 5-year Federal Supply Schedule (FSS) contract between the VA VHA and Novocure valued at up to $28.85 million, which allows the VA to efficiently procure Novocure's innovative cancer treatment equipment and services to support the VA's mission of providing veterans access to the latest medical technologies. The purchase order does not have a set-aside designation.

Generated 3/21/24, 11:58 PM